raltegravir

Of particular concern is the price of the UN World Health Organization-recommended third-line drug raltegravir – an integrase inhibitor that blocks retroviral replication – which costs up to US $5,870 per person per year in Brazil, compared with $675 in sub-Saharan Africa.

HIV and Aids: bad news for drug prices in middle-income countries 2011

Merck & Co, Inc., the manufacturer of raltegravir, supported both studies.

Raltegravir, the new antiretroviral treatment for HIV 2008

The study conducted at UNSW's National Centre in HIV Epidemiology and Clinical Research (NCHECR), shows that the majority of patients who have not responded to traditional retroviral treatments will have good results from a new combination therapy involving raltegravir.

Raltegravir, the new antiretroviral treatment for HIV 2008

MSD, had in a statement disclosed that its HIV drug, Isentress (raltegravir), was approved by US FDA in October 2007, and that the National Health Research and Ethics Committee (NHREC) and National Agency for Food and Drug Administration and Control (NAFDAC) have given their approval to the local study.

Experts Visit Nigeria Over New HIV Drug Trials 2008

It has also been observed that raltegravir lowers the amount of virus in the blood to undetectable levels in 62 percent of the people taking it in combination with other anti-HIV medicines.

Raltegravir, the new antiretroviral treatment for HIV 2008

The new drugs are Pfizer's maraviroc, Merck's raltegravir and Gilead's elvitegravir who thinks up these names?

Archive 2007-03-01 Ron Buckmire 2007

The drugs raltegravir and elvitegravir are called integrase inhibitors, which target HIV by inhibiting from using integrase, one of the three enzymes the virus uses to replicate itself in CD4 immune cells.

Archive 2007-03-01 Ron Buckmire 2007

Isentress, known generically as raltegravir, would be the first drug on the market to target a third enzyme -- integrase -- that helps the virus insert its DNA into that of human cells.

Merck's New AIDS Drug Has Promise -- if It Isn't Too Pricey 2007

The new drugs are Pfizer's maraviroc, Merck's raltegravir and Gilead's elvitegravir who thinks up these names?

AIDS Conference in Los Angeles Ends With A Bang Ron Buckmire 2007

The drugs raltegravir and elvitegravir are called integrase inhibitors, which target HIV by inhibiting from using integrase, one of the three enzymes the virus uses to replicate itself in CD4 immune cells.

AIDS Conference in Los Angeles Ends With A Bang Ron Buckmire 2007